Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT
Xilio Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 89.07M | 55.29M | 61.26M | 74.95M | 33.98M | 44.7M | 59.77M | 75.38M | 93.27M | 120.39M | 139.14M | 159.41M | 176.96M | 198.05M | 99.77M | 120.3M | 141.22M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 1.77M | 2.76M | 1.59M | 1.58M | 1.57M | 1.57M | 1.56M | 1.56M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M |
Other Long-Term Assets | 1.79M | 1.78M | 1.77M | 92K | 121K | 11K | 169K | 197K | 3.94M | 267K | 301K | 335K | 359K | -3.15M | 427K | 436K | 470K |
Receivables | n/a | n/a | n/a | n/a | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.13M | 4.94M | 2.05M | 3.06M | 5.21M | 3.42M | 4.71M | 3.04M | 3.71M | 4.11M | 3.17M | 3.6M | 4.13M | 4.46M | 3.4M | 2.35M | 230K |
Total Current Assets | 93.2M | 60.23M | 63.31M | 78.01M | 69.19M | 48.13M | 64.48M | 78.42M | 93.27M | 124.5M | 142.31M | 163.01M | 181.09M | 202.52M | 105.57M | 124.59M | 142.62M |
Property-Plant & Equipment | 8.73M | 9.06M | 9.57M | 10M | 10.54M | 11.2M | 11.61M | 12.16M | 12.73M | 12.84M | 13.24M | 13.23M | 13.35M | 13.6M | 13.17M | 13.45M | 13.7M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.09M | n/a | n/a | n/a |
Total Long-Term Assets | 10.52M | 10.84M | 11.35M | 11.87M | 13.42M | 12.8M | 13.36M | 13.93M | 18.23M | 14.67M | 15.1M | 15.12M | 15.27M | 15.54M | 15.15M | 15.44M | 15.72M |
Total Assets | 103.72M | 71.08M | 74.66M | 89.87M | 82.61M | 60.93M | 77.84M | 92.36M | 111.5M | 139.16M | 157.41M | 178.13M | 196.35M | 218.06M | 120.72M | 140.02M | 158.34M |
Account Payables | 2.27M | 2.57M | 972K | 1.26M | 746K | 1.05M | 1.49M | 945K | 2.01M | 3.13M | 1.81M | 1.41M | 2.32M | 3.14M | 3.82M | 8.41M | 2.61M |
Deferred Revenue | 40.25M | 13.52M | 26.11M | 26.52M | 21.73M | n/a | 9.4M | 7.14M | n/a | n/a | n/a | 12.09M | n/a | 8.75M | 8.19M | 8.07M | n/a |
Short-Term Debt | n/a | n/a | n/a | 1.12M | n/a | 1.05M | 1.01M | 981K | 6.67M | 6.67M | 5.89M | 4.19M | 2.5M | n/a | 773K | 4M | 4.05M |
Other Current Liabilities | 1.43M | 4.21M | 3.36M | 6.12M | 6.67M | 9.17M | 9.36M | 10.61M | 82K | 82K | 4.53M | 8.32M | 5.09M | 82K | 4.4M | 6.17M | 8.71M |
Total Current Liabilities | 47.64M | 27.26M | 38.02M | 38.64M | 31.58M | 15.96M | 16.93M | 16.29M | 16.19M | 21.12M | 16.84M | 17.77M | 12.22M | 12.78M | 12.87M | 21.3M | 16.29M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 8.14M | 8.41M | n/a | 1.55M | 3.17M | 4.78M | 6.39M | 8.01M | 9.63M | 19.9M | 5.48M | 6.45M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | -8.14M | n/a | 7K | 26K | 45K | 64K | 82K | 100K | 118K | 214.1M | 224.03M | 1.13M |
Total Long-Term Liabilities | 45.38M | 26.22M | 15.66M | 17.82M | 25.26M | 8.14M | 8.41M | 8.69M | 10.52M | 12.4M | 14.27M | 16.14M | 18.01M | 19.85M | 244.31M | 240.03M | 18.3M |
Total Liabilities | 93.02M | 53.48M | 53.68M | 56.46M | 56.84M | 24.1M | 25.34M | 24.98M | 26.71M | 33.52M | 31.12M | 33.91M | 30.23M | 32.63M | 257.18M | 261.33M | 34.59M |
Total Debt | 7.86M | 8.14M | 8.41M | 8.68M | 8.94M | 12.55M | 14.39M | 16.81M | 18.11M | 19.94M | 20.1M | 20.25M | 20.4M | 20.54M | 20.67M | 20.75M | 21.22M |
Common Stock | 5K | 5K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | n/a | 1K | 1K |
Retained Earnings | -397.02M | -383.75M | -370.66M | -356.64M | -342.71M | -325.51M | -307.86M | -291.11M | -271.75M | -249.11M | -226.64M | -206.85M | -182.24M | -160.89M | -141.19M | -124.93M | -101.75M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | -222.89M | -0.00 |
Shareholders Equity | 10.7M | 17.6M | 20.97M | 33.42M | 25.77M | 36.83M | 52.5M | 67.38M | 84.79M | 105.65M | 126.3M | 144.22M | 166.12M | 185.43M | -136.46M | -121.31M | 123.75M |
Total Investments | n/a | n/a | n/a | 1.77M | 2.76M | 1.59M | 1.58M | 1.57M | 1.57M | 1.56M | 1.56M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M |